Risk Prediction of Contrast-Induced Nephropathy
- 23 February 2006
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 98 (6), 27-36
- https://doi.org/10.1016/j.amjcard.2006.01.022
Abstract
No abstract availableKeywords
This publication has 102 references indexed in Scilit:
- N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-upAmerican Heart Journal, 2004
- Slowing the progression of diabetic nephropathy and its cardiovascular consequencesAmerican Heart Journal, 2004
- Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary interventionThe American Journal of Cardiology, 2004
- Impact of nephropathy after percutaneous coronary intervention and a method for risk stratificationThe American Journal of Cardiology, 2004
- Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiographyAmerican Heart Journal, 2003
- Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopamThe American Journal of Cardiology, 2002
- Use of dopamine in prevention of contrast induced acute renal failure — A randomised studyInternational Journal of Cardiology, 1996
- Metastatic Renal Cell CancerJournal of Immunotherapy, 1991
- Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or BothNew England Journal of Medicine, 1989
- Acute renal dysfunction after major arteriographyAmerican Journal of Roentgenology, 1985